Event study analysis in cases with multiple brand-generic reverse-payment settlements
Year of publication: |
2019
|
---|---|
Authors: | Hartman, Raymond S. ; Drake, Keith M. ; McGuire, Thomas G. |
Subject: | Antitrust | Event studies | Patent settlements | Pharmaceuticals | Reverse payment | Ereignisstudie | Event study | Patent | Pharmaindustrie | Pharmaceutical industry | Zahlungsverkehr | Payment transactions | Ankündigungseffekt | Announcement effect | Arzneimittel | Börsenkurs | Share price | Theorie | Theory |
-
Do "reverse payment" settlements constitute an anticompetitive pay-for-delay?
Drake, Keith M., (2015)
-
Delayed entry settlements at the patent office
Hovenkamp, Erik, (2018)
-
Competition in the pharmaceutical industry : the case of PAH drugs
Green, Kevin C., (2009)
- More ...
-
No free launch : at-risk entry by generic drug firms
Drake, Keith M., (2022)
-
Drake, Keith M., (2024)
-
Drake, Keith M., (2014)
- More ...